Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-29

Clinical Trial Update: Clinical Trial of Trametes Versicolor in Women With Breast Cancer [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial evaluating Trametes Versicolor in women with breast cancer. The study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trametes Versicolor

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED